97 results
424B5
NBSE
NeuBase Therapeutics Inc
30 Jun 23
Prospectus supplement for primary offering
8:42am
the authorized number of directors and to elect a director to fill a vacancy created by the expansion of our board of directors or the death, resignation
424B5
NBSE
NeuBase Therapeutics Inc
29 Dec 22
Prospectus supplement for primary offering
5:03pm
created by the expansion of our board of directors or the death, resignation, disqualification, retirement or removal of a director, which prevents
8-K
EX-10.1
r4juifcslw9ycsi
10 Jan 22
NeuBase Therapeutics Appoints Todd P. Branning Chief Financial Officer
4:06pm
424B5
kxw6m4w sg5xigq
27 Aug 21
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.2
8dlinhw4cd0ygk2jz1
8 Jun 21
Regulation FD Disclosure
2:01pm
8-K
EX-10.1
0x9df7xg1mnsm3
25 May 21
NeuBase Therapeutics Appoints Dr. Kia Motesharei Chief Business and Strategy Officer
9:00am
8-K
EX-10.1
rf1z8kyc8xqxcx8
20 May 21
NeuBase Therapeutics Appoints Dr. Sandra Rojas-Caro Chief Medical Officer
9:00am
424B5
gkdy zhvub6aq46g5
23 Apr 21
Prospectus supplement for primary offering
4:05pm
424B5
uvqgmk
21 Apr 21
Prospectus supplement for primary offering
4:03pm
8-K
EX-99.1
kx7iv
16 Dec 20
Regulation FD Disclosure
9:00am